|
ID |
DDInter1331 |
Drug Type |
small molecule |
Molecular Formula |
C21H26N2O5 |
Molecular Weight |
386.448
|
Description |
Olodaterol is a long-acting beta2-adrenergic agonist used in the management of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
|
ATC Classification |
R03AL06
R03AC19
|
IUPAC Name |
6-Hydroxy-8-[(1R)-1-Hydroxy-2-{[1-(4-Methoxyphenyl)-2-Methylpropan-2-Yl]Amino}Ethyl]-3,4-Dihydro-2H-1,4-Benzoxazin-3-One |
InChI |
Inchi=1S/C21H26N2O5/C1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17/H4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26)/T18-/M0/S1 |
InChI Key |
COUYJEVMBVSIHV-SFHVURJKSA-N |
Canonical SMILES |
COC1=CC=C(CC(C)(C)NC[C@H](O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1 |
Useful Links |
DrugBank
ChEMBL
PubChem
|